Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06258174 · ClinicalTrials.gov registry record · Phase 1

A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants

A Phase 1 study of Healthy, sponsored by Eli Lilly and Company.

Completed
Registry status
Phase 1
Development phase
28
Enrollment target
1
Study location

NCT06258174 is a Phase 1 study of Healthy that has completed, run by Eli Lilly and Company. The registered enrollment target is 28 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06258174, a Phase 1 study of Healthy, has completed, sponsored by Eli Lilly and Company.

COMPLETED
Registry status
Phase 1
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to compare two different formulations (mixtures) of pirtobrutinib (LOXO-305) in healthy participants. This study will compare how much of each formulation gets into the blood stream and how long it takes the body to remove it. Information about any side effects that may occur will be collected. The study will last up to 65 days.

Conditions Studied

Healthy

Interventions

  • DRUG Pirtobrutinib

Study Locations (1)

Texas

  • Labcorp Drug Development - Dallas

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2021-09-28
Est. Completion 2021-12-22
Phase Phase 1

Sponsor

Eli Lilly and Company

1,341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06258174

The ClinicalTrials.gov registry entry for NCT06258174 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Pirtobrutinib is the first listed.

NCT06258174 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06258174 about?

NCT06258174 is a clinical study titled "A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants". The main purpose of this study is to compare two different formulations (mixtures) of pirtobrutinib (LOXO-305) in healthy participants. This study will compare how much of each formulation gets into the blood stream and how long it takes the body to remove it. Information about any side effects that...

What is the current status of trial NCT06258174?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2021-09-28. Estimated completion is 2021-12-22.

What conditions does trial NCT06258174 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06258174?

The interventions under investigation include: Pirtobrutinib (DRUG).

Who is sponsoring clinical trial NCT06258174?

This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06258174 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.